A new drug blocks a protein that helps glioblastoma grow
Original title: Resistance-Mutant Rescue Establishes On-Target CHI3L1 Inhibition by CHI-DEL, a Brain-Penetrant Small Molecule with In Vivo Efficacy in Glioblastoma
How far along is this research?
This is a preprint. Other scientists have not checked it yet, so treat it as an early signal rather than an answer.
This was only tested in lab cells and in animals, not in people.
The short version
Scientists made a drug that blocks a protein tied to glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary growth.
What was studied. Researchers searched a large collection of small molecules. They found one they call CHI-DEL. It sticks to a protein called CHI3L1, also known as YKL-40. They tested it in lab cells, in human brain immune cells grown from stem cells, and in animals.
What they found. The drug sticks to one exact spot on the protein. When the team changed that spot, the drug stopped working. That shows the drug really acts on CHI3L1 and not something else. In cells, it slowed tumor growth and spread and turned down tumor signals. In animals, it got into the brain and the tumor. Higher doses helped the animals live longer.
What this means, and what it doesn't
What it could mean: CHI3L1 may be a real target for future glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary drugs. This work gives solid proof that the drug hits that target. The drug also reaches the brain, which many drugs cannot do. That makes it worth more study.
What it doesn't mean: This is early work, far from everyday care. The drug was only tested in cells and in animals. No people have taken it. It is not approved, and no doctor can give it to you. It is not a cure, and it is not a promise of one. Many more years of testing would be needed first.
Source: bioRxiv (preprint), October 24, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.